Mark Connor
24PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Aug 13, 2024
Activation of CB2 Receptors by (-)-Cannabichromene but Not (+)-Cannabichromene.Michael Udoh, Marina Santiago, Syed Haneef
|May 27, 2024
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.Tahira Foyzun, Maddie Whiting, Kate K Velasco
|Jul 27, 2023
Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands.Annukka Kallinen, Karine Mardon, Samuel Lane
|Apr 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.Richard C Kevin, Somayeh Mirlohi, Jamie J Manning
|Apr 11, 2022
Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues.Jack Markham, Eric Sparkes, Rochelle Boyd
|Mar 28, 2022
Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro.Somayeh Mirlohi, Chris Bladen, Marina J Santiago
Pageof 4
Frequent Collaborators
7 joint publications
Samuel D Banister
6 joint publications
Michelle Glass
6 joint publications
Marina Santiago
4 joint publications
Michael Kassiou
4 joint publications
Richard C Kevin
3 joint publications
David Hibbs
3 joint publications
Jamie J Manning
3 joint publications
Natasha L Grimsey
2 joint publications
Shivani Sachdev
1 joint publications
Jessie C Jacobsen
